Works matching IS 03065251 AND DT 2022 AND VI 88 AND IP 1

Results: 44

Issue Highlights.

Published in:: British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 3, doi. 10.1111/bcp.15228
Publication type:: Article

Anthony Peck (1933–2021).

Published in:

2022

By:

Cohen, Adam;
Fowle, Arthur S. E.

Publication type:

Obituary

Introduction to a series of Pro/Con papers in Clinical Toxicology.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 56, doi. 10.1111/bcp.15128

By:

Dear, James W.;
Dargan, Paul I.;
Juurlink, David N.;
Thanacoody, Ruben H. K.;
Wood, David M.

Publication type:

Article

Physostigmine should be used more readily for antimuscarinic toxicity: CON.

Published in:: British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 61, doi. 10.1111/bcp.15121
Publication type:: Article

Physostigmine should be used more readily for antimuscarinic toxicity: PRO.

Published in:: British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 58, doi. 10.1111/bcp.15120
Publication type:: Article

Ethics in clinical pharmacology: Facilitating public trust.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 5, doi. 10.1111/bcp.15118

By:

Magavern, Emma F.;
Piasecki, Jan;
Cohen, Adam;
Cremers, Serge

Publication type:

Article

Health equality, race and pharmacogenomics.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 27, doi. 10.1111/bcp.14983

By:

Magavern, Emma F.;
Gurdasani, Deepti;
Ng, Fu L.;
Lee, Sandra Soo‐Jin

Publication type:

Article

A placebo‐controlled investigation of the analgesic effects, abuse liability, safety and tolerability of a range of oral cannabidiol doses in healthy humans.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 347, doi. 10.1111/bcp.14973

By:

Arout, Caroline A.;
Haney, Margaret;
Herrmann, Evan S.;
Bedi, Gillinder;
Cooper, Ziva D.

Publication type:

Article

Hospitalization for adverse events under abiraterone or enzalutamide exposure in real‐world setting: A French population‐based study on prostate cancer patients.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 336, doi. 10.1111/bcp.14972

By:

Scailteux, Lucie‐Marie;
Despas, Fabien;
Balusson, Frédéric;
Campillo‐Gimenez, Boris;
Mathieu, Romain;
Vincendeau, Sébastien;
Happe, André;
Nowak, Emmanuel;
Kerbrat, Sandrine;
Oger, Emmanuel

Publication type:

Article

Population pharmacokinetic‐pharmacodynamic model‐based exploration of alternative ustekinumab dosage regimens for patients with Crohn's disease.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 323, doi. 10.1111/bcp.14971

By:

Wang, Zhigang;
Verstockt, Bram;
Sabino, João;
Vermeire, Séverine;
Ferrante, Marc;
Declerck, Paul;
Dreesen, Erwin

Publication type:

Article

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 311, doi. 10.1111/bcp.14970

By:

Yen, Fu‐Shun;
Huang, Yi‐Hsiang;
Hou, Ming‐Chih;
Hwu, Chii‐Min;
Lo, Yu‐Ru;
Shin, Shyi‐Jang;
Hsu, Chih‐Cheng

Publication type:

Article

Dose equivalence between metaraminol and norepinephrine in critical care.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 303, doi. 10.1111/bcp.14969

By:

Abu Sardaneh, Arwa;
Goradia, Shruti;
Narayan, Sujita W.;
Penm, Jonathan;
McLachlan, Andrew J.;
Patanwala, Asad E.

Publication type:

Article

Ethical aspects of facilitating the recruitment of people with dementia for clinical trials: A call for further debate.

Published in:: British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 22, doi. 10.1111/bcp.14968
Publication type:: Article

Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 64, doi. 10.1111/bcp.14964

By:

Islam, Saiful;
Wang, Shudong;
Bowden, Nikola;
Martin, Jennifer;
Head, Richard

Publication type:

Article

A population physiologically‐based pharmacokinetic model to characterize antibody disposition in pediatrics and evaluation of the model using infliximab.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 290, doi. 10.1111/bcp.14963

By:

Chang, Hsuan Ping;
Shakhnovich, Valentina;
Frymoyer, Adam;
Funk, Ryan Sol;
Becker, Mara L.;
Park, K. T.;
Shah, Dhaval K.

Publication type:

Article

Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real‐world vs. clinical‐trial evidence.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 282, doi. 10.1111/bcp.14961

By:

Ding, Wern Yew;
Rivera‐Caravaca, José Miguel;
Marín, Francisco;
Li, Guowei;
Roldán, Vanessa;
Lip, Gregory Y. H.

Publication type:

Article

Prediction of maternal and fetal pharmacokinetics of indomethacin in pregnancy.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 271, doi. 10.1111/bcp.14960

By:

Pillai, Venkateswaran C.;
Shah, Mansi;
Rytting, Erik;
Nanovskaya, Tatiana N.;
Wang, Xiaoming;
Clark, Shannon M.;
Ahmed, Mahmoud S.;
Hankins, Gary D. V.;
Caritis, Steve N.;
Venkataramanan, Raman

Publication type:

Article

Characterisation of pharmacokinetics, safety and tolerability in a first‐in‐human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 260, doi. 10.1111/bcp.14956

By:

Sadiq, Muhammad Waqas;
Asimus, Sara;
Belvisi, Maria G.;
Brailsford, Wayne;
Fransson, Rebecca;
Fuhr, Rainard;
Hagberg, Anette;
Hashemi, Mahdi;
Jellesmark Jensen, Tina;
Jonsson, Julia;
Keen, Christina;
Körnicke, Thomas;
Kristensson, Cecilia;
Mäenpää, Jukka;
Necander, Sofia;
Nemes, Szilárd;
Betts, Joanne

Publication type:

Article

Model‐informed precision dosing for alemtuzumab in paediatric and young adult patients undergoing allogeneic haematopoietic cell transplantation.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 248, doi. 10.1111/bcp.14955

By:

Dong, Min;
Emoto, Chie;
Fukuda, Tsuyoshi;
Arnold, Danielle E.;
Mehta, Parinda A.;
Marsh, Rebecca A.;
Vinks, Alexander A.

Publication type:

Article

Evaluation of the pharmacokinetics of pemigatinib in patients with impaired hepatic or renal function.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 237, doi. 10.1111/bcp.14954

By:

Ji, Tao;
Rockich, Kevin;
Epstein, Noam;
Overholt, Heather;
Wang, Phillip;
Chen, Xuejun;
Punwani, Naresh;
Yeleswaram, Swamy

Publication type:

Article

The CredibleMeds<sup>®</sup> list: Usage of QT interval prolonging drugs in Germany and discordances with prescribing information.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 226, doi. 10.1111/bcp.14951

By:

Then, Melanie I.;
Andrikyan, Wahram;
Maas, Renke;
Fromm, Martin F.

Publication type:

Article

Mirtazapine use may increase the risk of hypothyroxinaemia in patients affected by major depressive disorder.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 214, doi. 10.1111/bcp.14949

By:

Zhao, Ying;
Wang, Na;
Wen, Shi Wu;
Li, Mingcan;
Yuan, Yuan;
Retnakaran, Ravi;
Hao, Wei;
Zhang, Ruiling;
Zhai, Desheng

Publication type:

Article

Implementing a specialist paediatric clinical pharmacology service in a UK children's hospital.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 206, doi. 10.1111/bcp.14944

By:

Hawcutt, Daniel B.;
Warner, Naomi;
Kenyon, Elaine;
Murray, Christine;
Taylor, Julia;
Moss, James;
McWilliam, Stephen;
Weston, Will;
Murdock, Nicki

Publication type:

Article

Precision medicine and theranostics using radiopharmaceuticals in oncology.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 359, doi. 10.1111/bcp.14942

By:

te Beek, Erik T.;
Teunissen, Jaap J. M.;
Postema, Jan W. A.;
Lafeber, Albert;
ten Broek, Marc R. J.

Publication type:

Article

Comment on "The effectiveness and safety of topical beta‐receptor blocker in treating superficial infantile haemangiomas: A meta‐analysis including 20 studies".

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 358, doi. 10.1111/bcp.14941

By:

Sun, Bin;
Dong, Changxian;
Lei, Hongzhao;
Ma, Yuchun

Publication type:

Article

Levetiracetam in lactation: How much is excreted into human breast milk?

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 199, doi. 10.1111/bcp.14940

By:

Dinavitser, Natalie;
Kohn, Elkana;
Berlin, Maya;
Brandriss, Nurit;
Bar‐Chaim, Adina;
Keidar, Rimona;
Livne, Ayelet;
Stepensky, David;
Berkovitch, Matitiahu;
Sheinberg, Revital

Publication type:

Article

Omecamtiv mecarbil does not prolong QTc intervals at therapeutic concentrations.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 187, doi. 10.1111/bcp.14939

By:

Trivedi, Ashit;
Hsu, Cheng‐Pang;
Jafarinasabian, Pegah;
Terminello, Bianca;
Zhang, Hanze;
Flach, Stephen;
Israel, Samuel;
Brooks, Ashley;
Xue, Hongqi;
Darpo, Borje;
Abbasi, Siddique;
Dutta, Sandeep;
Lee, Edward

Publication type:

Article

The association between increasing oral anticoagulant prescribing and atrial fibrillation related stroke in Ireland.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 178, doi. 10.1111/bcp.14938

By:

Kennedy, Cormac;
Gabr, Ahmed;
McCormack, Joan;
Collins, Rónán;
Barry, Michael;
Harbison, Joe

Publication type:

Article

Relevance of primary lesion location, tumour heterogeneity and genetic mutation demonstrated through tumour growth inhibition and overall survival modelling in metastatic colorectal cancer.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 166, doi. 10.1111/bcp.14937

By:

Vera‐Yunca, Diego;
Parra‐Guillen, Zinnia P.;
Girard, Pascal;
Trocóniz, Iñaki F.;
Terranova, Nadia

Publication type:

Article

Corticosteroid use, myocardial injury and in‐hospital cardiovascular events in patients with community‐acquired pneumonia.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 155, doi. 10.1111/bcp.14936

By:

Cangemi, Roberto;
Carnevale, Roberto;
Cammisotto, Vittoria;
Nocella, Cristina;
Bartimoccia, Simona;
Taliani, Gloria;
Falcone, Marco;
Calvieri, Camilla;
Pignatelli, Pasquale;
Violi, Francesco

Publication type:

Article

Comparison of effectiveness and safety between ticagrelor and clopidogrel in patients with acute coronary syndrome and on dialysis in Taiwan.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 145, doi. 10.1111/bcp.14935

By:

Li, Yun‐Syuan;
Wang, Shih‐Han;
Hwang, Shang‐Jyh;
Yang, Yi‐Hsin;
Hsieh, Kun‐Pin

Publication type:

Article

Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 138, doi. 10.1111/bcp.14934

By:

Huh, Ki Young;
Chung, Hyewon;
Kim, Yu Kyong;
Lee, SeungHwan;
Bhatia, Siddharth;
Takanami, Yohei;
Nakaya, Ryou;
Yu, Kyung‐Sang

Publication type:

Article

Concentration‐QT modelling of the novel DHFR inhibitor P218 in healthy male volunteers.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 128, doi. 10.1111/bcp.14933

By:

Täubel, Jӧrg;
Lorch, Ulrike;
Ferber, Georg;
Spencer, Christopher S.;
Freier, Anne;
Coates, Simon;
El Gaaloul, Myriam;
Donini, Cristina;
Chughlay, Mohamed Farouk;
Chalon, Stephan

Publication type:

Article

Test‐dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non‐malignant disorders.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 115, doi. 10.1111/bcp.14932

By:

Chandra, Sharat;
Mizuno, Kana;
Zhao, Junfang;
Davies, Stella M.;
Marsh, Rebecca A.;
Fukuda, Tsuyoshi;
Setchell, Kenneth D. R.;
Vinks, Alexander A.;
Mehta, Parinda A.

Publication type:

Article

First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 103, doi. 10.1111/bcp.14931

By:

Moss, Laurence M.;
Berends, Cecile L.;
van Brummelen, Emilie M. J.;
Kamerling, Ingrid M. C.;
Klaassen, Erica S.;
Bergmann, Kirsten;
Ville, Vanessa;
Juarez‐Perez, Victor;
Benichou, Annie‐Claude;
Groeneveld, Geert Jan

Publication type:

Article

Vitamin B12 inactivation may not be the only cause of acquired peripheral neuropathy in chronic nitrous oxide users.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 356, doi. 10.1111/bcp.14930

By:

Vodovar, Dominique;
Care, Weniko;
Batisse, Anne;
Dufayet, Laurène

Publication type:

Article

Pharmacokinetics of capmatinib in participants with hepatic impairment: A phase 1, open‐label, single‐dose, parallel‐group study.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 91, doi. 10.1111/bcp.14929

By:

Chen, Xinhui;
Cui, Xiaoming;
Pognan, Nathalie;
Quinlan, Michelle;
Kapoor, Shruti;
Rahmanzadeh, Gholamreza;
Giovannini, Monica;
Marbury, Thomas C.

Publication type:

Article

The impact of rifampicin on the pharmacokinetics of fuzuloparib in healthy Chinese male volunteers.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 84, doi. 10.1111/bcp.14926

By:

Zhang, Qiao;
Kai, Jiejing;
Zhai, You;
Xu, Nana;
Shentu, Jianzhong;
Zhang, Yanyan;
Liang, Yanjuan;
Wang, Yuya;
Wu, Lihua

Publication type:

Article

Ethical issues in therapeutic use and research in pregnant and breastfeeding women.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 7, doi. 10.1111/bcp.14914

By:

Weld, Ethel D.;
Bailey, Theodore C.;
Waitt, Catriona

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 1, doi. 10.1111/bcp.14900
Publication type:: Article

Tacrolimus variability score outperforms coefficient of variation in predicting clinical outcomes of living kidney transplantation.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 75, doi. 10.1111/bcp.14876

By:

Yin, Saifu;
Wang, Xianding;
Huang, Zhongli;
Fan, Yu;
Song, Turun;
Lin, Tao

Publication type:

Article

Ethics of vaccination: Should capability measures be used to inform SARS‐CoV‐2 vaccination strategies?

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 47, doi. 10.1111/bcp.14875

By:

Millar, Michael R.;
Gourtsoyannis, Yannis;
Jayakumar, Angelina

Publication type:

Article

Rethinking the role of Research Ethics Committees in the light of Regulation (EU) No 536/2014 on clinical trials and the COVID‐19 pandemic.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 40, doi. 10.1111/bcp.14871

By:

Tusino, Silvia;
Furfaro, Maria

Publication type:

Article

Promoting diseases to promote drugs: The role of the pharmaceutical industry in fostering good and bad medicalization.

Published in:: British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 34, doi. 10.1111/bcp.14835
Publication type:: Article